Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: LncRNA-PVT1 was identified as a key regulator for TMZ resistance and STAT-related pathway in glioma

Fig. 3

PVT1 was an unfavorable prognostic factor in glioma patients in CGGA cohort. (A-B) Kaplan–Meier survival analysis revealed a high level of PVT1 expression was an unfavorable prognostic factor in all grade patients and GBM patients. (C-H) Kaplan–Meier survival analysis based on PVT1 expression in stratified patients (MGMT methylated, MGMT un-methylated, chemotherapy, without chemotherapy, radiotherapy and without radiotherapy)

Back to article page